Cohere Inc. chief executive Aidan Gomez is criticizing calls from top leaders in artificial intelligence to slow the pace of ...

Der Ruf nach einer Verlangsamung des KI-Wettrennens stösst bei der Regierung in Washington auf Unverständnis. Präsident Trump ...

Anthropic CEO Dario Amodei is calling on artificial intelligence companies to slow the development of their most advanced models, a proposal that has drawn support from several other industry leaders.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Alarm grew after a researcher resigned, warning that the “people building AI earnestly believe that it could kill us all by ...

HyperVerge today launched a suite of AI agents for business loan underwriting at the Global Fintech Fest 2026. Built to close India’s ₹25 lakh crore credit gap for MSMEs, the suite of three AI agents ...

'We really do earnestly believe AI could kill all humans!' ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...